Literature DB >> 14985887

Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.

M M Gavra1, C Voumvourakis, A D Gouliamos, C Sfagos, L J Vlahos.   

Abstract

Our purpose was to evaluate the role of magnetization transfer and image subtraction in detecting more enhancing lesions in brain MR imaging of patients with multiple sclerosis (MS). Thirty-one MS patients underwent MR imaging of the brain with T1-weighted spin echo sequences without and with magnetization transfer (MT) using a 1.5 T imager. Both sequences were acquired before and after intravenous injection of a paramagnetic contrast agent. Subtraction images in T1-weighted sequences were obtained by subtracting the pre-contrast images from the post-contrast ones. A significant difference was found between the numbers of enhanced areas in post-gadolinium T1-weighted images without and with MT (p=0.020). The post-gadolinium T1-weighted images with MT allowed the detection of an increased (13) number of enhancing lesions compared with post-gadolinium T1-weighted images without MT. A significant difference was also found between the numbers of enhanced areas in post-gadolinium T1-weighted images without MT and subtraction images without MT (p=0.020). The subtraction images without MT allowed the detection of an increased (10) number of enhancing lesions compared with post-gadolinium T1-weighted images without MT. Magnetization transfer contrast and subtraction techniques appear to be the simplest and least time-consuming applications to improve the conspicuity and detection of contrast-enhancing lesions in patients with MS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985887     DOI: 10.1007/s00234-003-1146-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

Review 1.  The role of magnetic resonance in the assessment of multiple sclerosis.

Authors:  M Rovaris; M Filippi
Journal:  J Neurol Sci       Date:  2000-01-15       Impact factor: 3.181

2.  Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.

Authors:  P D Molyneux; P S Tofts; A Fletcher; B Gunn; P Robinson; H Gallagher; I F Moseley; G J Barker; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

3.  Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer.

Authors:  R C Mehta; G B Pike; D R Enzmann
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

4.  Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.

Authors:  M Filippi; R Capra; A Campi; B Colombo; F Prandini; N Marcianò; R Gasparotti; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

5.  Improvement of post-gadolinium contrast with magnetization transfer.

Authors:  P Huot; V Dousset; F Hatier; P Degreze; P Carlier; J M Caillé
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

6.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Authors:  D H Miller; P S Albert; F Barkhof; G Francis; J A Frank; S Hodgkinson; F D Lublin; D W Paty; S C Reingold; J Simon
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

7.  Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis.

Authors:  M Filippi; M A Horsfield; M Rovaris; T Yousry; M A Rocca; C Baratti; S Bressi; G Comi
Journal:  AJNR Am J Neuroradiol       Date:  1998-02       Impact factor: 3.825

8.  Evaluation of Gd-enhancement in brain MR of multiple sclerosis: image subtraction with and without magnetization transfer.

Authors:  F Sardanelli; C Losacco; A Iozzelli; P Renzetti; E Rosso; R C Parodi; M Bonetti; A Murialdo
Journal:  Eur Radiol       Date:  2002-02-05       Impact factor: 5.315

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  High-dose applications of gadolinium chelates in magnetic resonance imaging.

Authors:  V M Runge; J E Kirsch; G S Thomas
Journal:  Magn Reson Med       Date:  1991-12       Impact factor: 4.668

View more
  4 in total

1.  Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?

Authors:  Constantina Andrada Treabă; Rodica Bălaşa; Daniela Maria Podeanu; Iunius Paul Simu; Mircea Marian Buruian
Journal:  Diagn Interv Radiol       Date:  2014 Mar-Apr       Impact factor: 2.630

2.  Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.

Authors:  L L F do Amaral; D C Fragoso; R H Nunes; I A Littig; A J da Rocha
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

3.  Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3T.

Authors:  Richard Keith Downs; Mariah Haider Bashir; Chin Kau Ng; Jens Olaf Heidenreich
Journal:  Quant Imaging Med Surg       Date:  2013-06

4.  The relationship between enhanced plaques with Gadovist and Magnevist contrast brain magnetic resonance imaging and the neurological deficit in the acute phase of relapsing remitting multiple sclerosis.

Authors:  Mahboobeh Yaghoobi; Mohammad Hossein Harirchian; Kavous Firouznia; Somayeh Behzadi; Hassan Hashemi; Hossein Ghanaati; Madjid Shakiba; Amir Hossein Jalali; Shahrzad Mohebbi
Journal:  Iran J Neurol       Date:  2012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.